Get your free ETF data sample from our comprehensive offerings. Start your free trial

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

ETF screener

LFSC ETF · F/m Emerald Life Sciences Innovation ETF

The LFSC Exchange Traded Fund (ETF) is provided by Emerald Group. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofLife Sciences1M perf.+11.10%
Last price
$44.13
1M perf.
+11.10%
1M flows
+€1M
AuM
€100M
TER
0.79%
Rating
Not rated
ESG Consensus®
esg grade icon
LFSC
$44.13

Performance & flows

Segment for quartile rank
March 23, 2026 → June 23, 2026
0-5%0%5%10%15%20%25%30%APRMAYJUNAPRMAYJUN
Create a free account to view the flows graph
LFSC
$42.55
+26.23%
Life Sciences
+26.23%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
+11.10%
+26.23%
+74.95%
N/AN/A
+8.01%
+21.49%
+16.22%
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
CUSIP
74933W221
ISIN
US74933W2219
AuM
€100M
TER
0.79%
ESG Consensus®
esg grade icon
More details
NAV
6/23/2026
$42.55
1D NAV change
+0.42%
Dividend policy
No. of holdings
41
Inception date
10/31/2024
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Fund
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The Fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust (the “Sub-Adviser”)
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
+26.23%
+74.95%
N/A
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
90.57%
United Kingdom
7.41%
Unavailable
1.08%
Other
0.94%
Sectors
Health Care
72.84%
Sovereign
1.29%
Unavailable
25.87%
Diversification
Total weight of top 15 holdings out of 41
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Issuer

Emerald Group
Emerald Group ID Card
Number of funds
2
Total AuM
€128M
Expense ratio range
0.79% - 0.89%
Average expense ratio
0.84%
Top 2 funds by Emerald Group
AuM
LFSC
F/m Emerald Life Sciences Innovation ETF€100M
SPIT
F/m Emerald Special Situations ETF€28M

Frequently asked questions about LFSC

What does F/m Emerald Life Sciences Innovation ETF, LFSC, invest in?

LFSC is a Active ETF. This ETF provides exposure to Other Mid and Small-Cap Equities.

What is the Total Expense ratio (TER) of LFSC?

LFSC carries a total expense ratio (TER) of 0.79%, indicating the annual cost for holding the fund.

When was LFSC launched?

LFSC was introduced to the market on October 31, 2024. It trades on United States

Who is the ETF issuer of LFSC?

F/m Emerald Life Sciences Innovation ETF, LFSC, is provided by Emerald Group. Learn more about Emerald Group here.

What is the current assets under management (AUM) of LFSC?

LFSC oversees €100M in assets as of June 23, 2026.

How has LFSC performed lately?

Based on data from June 23, 2026, LFSC returned 11.10% over the past month, 26.23% over the last three months and 16.22% year-to-date.

What are the latest inflows or outflows for LFSC?

As of June 23, 2026, LFSC recorded net flows of +€1M over the last month and +€5.2M year-to-date.

Does LFSC distribute dividends?

LFSC follows a distributing dividend policy, meaning it pays out income to investors.

What are the main country or region exposures of LFSC?

As of May 31, 2026, LFSC has significant geographic allocations in USA and United Kingdom.

In which sector or theme does LFSC invest in?

As of May 31, 2026, LFSC focuses largely on Health Care and Sovereign.

How many securities does LFSC hold and how diversified is it?

As of May 31, 2026, LFSC holds 41 positions in its portfolio, with 69.62% of assets concentrated in its top 15 holdings.

What are the main positions in LFSC?

As of May 31, 2026, LFSC top three holdings include COGENT BIOSCIENCES, LIVANOVA and TRAVERE THERAPEUTICS INC.

What is the base currency of LFSC?

The base currency of LFSC is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight